|
Clinical Trials
|
Blaze is focused on developing Tumor Paint products and related therapeutics. Our first Tumor Paint product candidate, BLZ-100, is being developed for brain cancer surgery. Below is more information on our current clinical trial for BLZ-100.
BLZ-100: Pediatric brain cancer (U.S.) Title: A Randomized, Blinded Study of Fluorescence Detection of Pediatric Primary Central Nervous System Tumors in Subjects Receiving Tozuleristide and Imaged With the Canvas System Status: Recruiting More information: For a link to the clinicaltrials.gov site, please click here. Blaze Bioscience Policy: Expanded Access to Investigational Drugs for Treatment Use 
| ||